Tuesday 11 October 2011

1P28: z) Design, synthesis and in vitro testing of α-methylacyl-CoA racemase inhibitors

The enzyme α-methylacyl-CoA racemase (AMACR) is overexpressed in prostate, colon, and other cancers and has been partially validated as a potential therapeutic target by siRNA knockdown of the AMACR gene. Analogs of the natural substrate branched chain α-methylacyl coenzyme A esters, possessing one or more β-fluorine atoms, have been synthesized using Wittig, conjugate addition and asymmetric aldol reactions and found to be reversible competitive inhibitors. The CoA esters were made from the racemic acids and tested as diastereoisomeric mixtures. For the synthesis of compounds 171 and 173, A. J. Carnell et al.68 employed an Evans asymmetric aldol reaction to have control over absolute and relative stereochemistry of the 2-methyl and 3-fluoro substituents (Scheme 28). Thus, asymmetric aldol reaction between the boron enolate derived from oxazolidinone 167 and the tetradecanal afforded the syn aldol product 168 as a single isomer.

_____________
68. A. J. Carnell, I. Hale, S. Denis, R. J. A. Wanders, W. B. Isaacs, B. A.  Wilson, and S. Ferdinandusse, J. Med. Chem.,2007, 50, 2700.
Next Page